Delegates attend Diabetes UK Professional Conference 2017
More than 2,000 delegates attended this year’s Diabetes UK Professional Conference in Manchester.
The annual event, which brings together healthcare professionals, researchers, pharmaceutical companies and anybody else with an interest in diabetes, was held at the Manchester Central Convention Complex.
This year’s message was all about research as according to Diabetes UK, for every £1 spent on diabetes care, only 0.5p is spent on trying to find a cure or better treatment.
Around £60 million is spent on diabetes research in the UK, but £500 million is set aside for cancer research. The charity said that as funding set aside for diabetes is not as much as in other research areas, this is “holding back progress on better care and treatment or finding a cure”.
One of the biggest highlights of the conference is the Named Lecturers, who provide the opportunity to share and discuss exciting developments in the field of diabetes.
This year the line-up included Professor Andrew Boulton, who has authored more than 500 peer-reviews manuscripts and has won many awards including the EASD Camillo Golgi prize.
Professor Solomon Tesfaye, who is a consultant physician and endocrinologist at Sheffield Teaching Hospitals and Honorary Professor of diabetic medicine at the University of Sheffield was also a Named Lecturer, along with Dr Paru King, who is a consultant in diabetes and endocrinology in Derby.
The charity’s chief executive Chris Askew said “Last year I opened the conference by saying there was a diabetes crisis. Since then the number of people living with diabetes has increased to 4.5 million and our response to the crisis has become more important than ever.
“Diabetes UK’s mission is that by bringing people together to work in partnership, we will support people to live with diabetes, prevent type 2, make research breakthroughs and ultimately find a cure.”
Some of the conference highlights included an update on the Healthier You: NHS Diabetes Prevention Programme, research on the EndoBarrier therapy and study findings on how whey protein could help control type 2 diabetes.